<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="19%"></col>
<col width="73%"></col>
<tbody>
<tr>
<td colspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Strong CYP3A4 Inhibitors</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Clinical Impact:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Concomitant use of REXULTI with strong CYP3A4 inhibitors increased the exposure of brexpiprazole compared to the use of REXULTI alone <content stylecode="italics">[see Clinical Pharmacology (<linkhtml href="#S12.3">12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Intervention:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of REXULTI with a strong CYP3A4 inhibitor, reduce the REXULTI dosage<content stylecode="italics"> [see </content>
<content stylecode="italics">
<linkhtml href="#S2.5">Dosage and Administration (2.5)</linkhtml>
</content>
<content stylecode="italics">]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Examples:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>itraconazole, clarithromycin, ketoconazole</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">Strong CYP2D6 Inhibitors*</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Clinical Impact:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Concomitant use of REXULTI with strong CYP2D6 inhibitors increased the exposure of brexpiprazole compared to the use of REXULTI alone <content stylecode="italics">[see <linkhtml href="#S12.3">Clinical Pharmacology (12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Intervention:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of REXULTI with a strong CYP2D6 inhibitor, reduce the REXULTI dosage <content stylecode="italics">[see </content>
<content stylecode="italics">
<linkhtml href="#S2.5">Dosage and Administration (2.5)</linkhtml>
</content>
<content stylecode="italics">]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Examples:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>paroxetine, fluoxetine, quinidine</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">Both CYP3A4 Inhibitors and CYP2D6 Inhibitors </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Clinical Impact:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Concomitant use of REXULTI with 1) a strong CYP3A4 inhibitor and a strong CYP2D6 inhibitor;  or 2) a moderate CYP3A4 inhibitor and a strong CYP2D6 inhibitor; or 3) a strong CYP3A4 inhibitor and a moderate CYP2D6 inhibitor; or 4) a moderate CYP3A4 inhibitor and a moderate CYP2D6 inhibitor, increased the exposure of brexpiprazole compared to the use of REXULTI alone <content stylecode="italics">[see </content>
<content stylecode="italics">
<linkhtml href="#S12.3">Clinical Pharmacology (12.3)</linkhtml>
</content>
<content stylecode="italics">]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Intervention:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of REXULTI with 1) a strong CYP3A4 inhibitor and a strong CYP2D6 inhibitor;  or 2) a moderate CYP3A4 inhibitor and a strong CYP2D6 inhibitor; or 3) a strong CYP3A4 inhibitor and a moderate CYP2D6 inhibitor; or 4) a moderate CYP3A4 inhibitor and a moderate CYP2D6 inhibitor,  decrease the REXULTI dosage <content stylecode="italics">[see </content>
<content stylecode="italics">
<linkhtml href="#S2.5">Dosage and Administration (2.5)</linkhtml>
</content>
<content stylecode="italics">]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Examples:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>1) itraconazole + quinidine</paragraph>
<paragraph>2) fluconazole + paroxetine </paragraph>
<paragraph>3) itraconazole + duloxetine</paragraph>
<paragraph>4) fluconazole + duloxetine</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">Strong CYP3A4 Inducers </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Clinical Impact:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Concomitant use of REXULTI and a strong CYP3A4 inhibitor decreased the exposure of brexpiprazole compared to the use of REXULTI alone <content stylecode="italics">[see <linkhtml href="#S12.3">Clinical Pharmacology (12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="italics">Intervention:</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of REXULTI with a strong CYP3A4 inducer, increase the REXULTI dosage <content stylecode="italics">[see </content>
<content stylecode="italics">
<linkhtml href="#S2.5">Dosage and Administration (2.5)</linkhtml>
</content>
<content stylecode="italics">]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="italics">Examples:</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>rifampin, St. Johnâ€™s wort</paragraph>
</td>
</tr>
</tbody>
</table>